Trials / Conditions / Immunoglobulin A Nephropathy (IgAN)
Immunoglobulin A Nephropathy (IgAN)
5 registered clinical trials studyying Immunoglobulin A Nephropathy (IgAN) — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Chinese Adults With Kidney Disease NCT07522099 | ADARx Pharmaceuticals, Inc. | Phase 2 |
| Recruiting | A Study to Assess the Effects of Zigakibart on IgA Nephropathy. NCT07146906 | Novartis Pharmaceuticals | Phase 2 |
| Not Yet Recruiting | Efficacy and Safety Study of HS-10542 for IgA Nephropathy NCT07474636 | Jiangsu Hansoh Pharmaceutical Co., Ltd. | Phase 2 |
| Enrolling By Invitation | A Study of Cizutamig in Patients With Immunoglobulin A Nephropathy NCT07135219 | Peking University First Hospital | EARLY_Phase 1 |
| Recruiting | A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) NCT06935357 | Biogen | Phase 3 |